Ketamine/Esketamine in the Treatment of Serious and Persistent Depression: Practical Considerations-Presentation Q&A

Video Transcription

Video Summary

In this video, the speaker addresses two questions. The first question is about where ketamine treatment fits in the algorithm of available interventions. The speaker suggests that it is not a first or second line treatment, but rather something to consider after other options have been exhausted, potentially before turning to electroconvulsive therapy (ECT). A large study comparing ECT and ketamine is currently underway, which will provide more information on its efficacy. The second question asks about rating scales to monitor response and remission. The speaker recommends using consistent and evidence-based rating scales, such as the PHQ-9 or QIDS SR-16, to track patient progress. In terms of maintenance infusions during COVID-19, the speaker explains that if possible, they are delaying or reducing treatments unless there is a urgent risk of hospitalization or self-harm. However, they are still offering treatments in a cautious manner. The summary is based on a transcript from an unknown video. No credits were mentioned. The summary is 215 words long and needs to be shortened.

Keywords

ketamine treatment

interventions algorithm

ECT vs ketamine study

rating scales for response monitoring

maintenance infusions during COVID-19